771
771
复制标题
第771章
DOI:
10.1097/01.ccm.0000551520.99228.47
复制
发表时间:
2019
影响因子:
8.8
通讯作者:
M. Miksa
中科院分区:
文献类型:
--
作者:
M. Miksa
Methods: This Case report presents a 5-year-old male with known argininemia, who was on special diet (UCD anamix) and glycerol phenylbutyrate since he presented shortly after birth. He had minimal symptoms and normal developmental delay (baseline modified Rankin Scale 1). He presented to the PICU after a two day history of nausea, vomiting, with status epilepticus and posturing. His CT head showed significant generalized cerebral edema and his ammonia level was initially 450 µmol/L. A decompressive bifrontal craniectomy was not an option, rather medical management with ammonul, and highly protocolized ICP/CPP management (based on the neurocritical care society standards) were used guided by a intraparenchymal Raumedic ICP/tPbO2 monitor). ICP spikes peaked at 40 mmHg and tPbO2 had dropped to< 5 in the initial 24 hrs. He was induced in a pentobarbital coma and cooled to 34 degrees for 2 weeks and then slowly weaned off medications. 3 months after presentation he presented to a neurology clinic followup and was able to walk, talk and write and read in two languages, He retained a mild tremor that has gotten better over time (mRS: 2).Results: This outstanding outcome in a child with severe hyperammonemia and cerebral edema that appeared refractory to treatment shows, that particularly in patients with UCD, we still do not fully understand the underlying mechanism of cerebral edema, intracellular metabolism, and cerebrovascular dysregulation. It is therefore important not to “give up” and withdraw from maximal medical management despite prolonged ICP peaks with subjective dire prognosis.